143 related articles for article (PubMed ID: 32243306)
1. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.
Cheung LC; Egemen D; Chen X; Katki HA; Demarco M; Wiser AL; Perkins RB; Guido RS; Wentzensen N; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):90-101. PubMed ID: 32243306
[TBL] [Abstract][Full Text] [Related]
2. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Egemen D; Cheung LC; Chen X; Demarco M; Perkins RB; Kinney W; Poitras N; Befano B; Locke A; Guido RS; Wiser AL; Gage JC; Katki HA; Wentzensen N; Castle PE; Schiffman M; Lorey TS
J Low Genit Tract Dis; 2020 Apr; 24(2):132-143. PubMed ID: 32243308
[TBL] [Abstract][Full Text] [Related]
3. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Demarco M; Egemen D; Raine-Bennett TR; Cheung LC; Befano B; Poitras NE; Lorey TS; Chen X; Gage JC; Castle PE; Wentzensen N; Perkins RB; Guido RS; Schiffman M
J Low Genit Tract Dis; 2020 Apr; 24(2):144-147. PubMed ID: 32243309
[TBL] [Abstract][Full Text] [Related]
4. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
5. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
6. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
7. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
8. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
[No Abstract] [Full Text] [Related]
9. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
10. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Schiffman M; Wentzensen N; Perkins RB; Guido RS
J Low Genit Tract Dis; 2020 Apr; 24(2):87-89. PubMed ID: 32243305
[No Abstract] [Full Text] [Related]
11. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
[TBL] [Abstract][Full Text] [Related]
12. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
Kim JJ; Burger EA; Regan C; Sy S
JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
[TBL] [Abstract][Full Text] [Related]
13. Making Sense of Cervical Cancer Screening Guidelines and Recommendations.
Davis M; Feldman S
Curr Treat Options Oncol; 2015 Dec; 16(12):55. PubMed ID: 26467929
[TBL] [Abstract][Full Text] [Related]
14. Benefits of Cervical Cancer Screening by Liquid-Based Cytology as Part of Routine Antenatal Assessment.
Parkpinyo N; Inthasorn P; Laiwejpithaya S; Punnarat T
Asian Pac J Cancer Prev; 2016; 17(9):4457-4461. PubMed ID: 27797261
[TBL] [Abstract][Full Text] [Related]
15. T Cell Receptor Repertoires Acquired
Christley S; Ostmeyer J; Quirk L; Zhang W; Sirak B; Giuliano AR; Zhang S; Monson N; Tiro J; Lucas E; Cowell LG
Front Immunol; 2021; 12():624230. PubMed ID: 33868241
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening: evidence behind the guidelines.
Lees BF; Erickson BK; Huh WK
Am J Obstet Gynecol; 2016 Apr; 214(4):438-443. PubMed ID: 26519782
[TBL] [Abstract][Full Text] [Related]
17. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
18. Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.
Roe CJ; Hanley KZ
Surg Pathol Clin; 2018 Sep; 11(3):589-599. PubMed ID: 30190142
[TBL] [Abstract][Full Text] [Related]
19. Cytology at the Time of HPV: Some Things to Think about when Discussing HPV.
Valentine K; Vanden Broeck D; Benoy I; Truyens M; Bogers J
Acta Cytol; 2016; 60(6):527-533. PubMed ID: 27816982
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and cervical disease in adolescents.
Guido R
Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
